Hardy Diagnostics releases a rapid test for the coronavirus
Hardy Diagnostics has announced the release of a rapid test for patients suspected of COVID-19 infection
Hardy Diagnostics has announced the release of a rapid test for patients suspected of COVID-19 infection
Roche Group has provided an update on the various actions the company is taking to address the COVID-19 pandemic
How Bioneer A/S is using state-of-the-art imaging technology to advance screening of 3D cancer spheroids and monitor neurite outgrowth
Chairman and CEO Albert Bourla calls on biopharma industry to collaborate on combating the global pandemic
Join this webinar to find out how 3D cell culture overcomes the limitations of traditional 2D culture
Originally scheduled from March 11–15, the event has been postponed and will now take place from October 19–22, 2020
We put your most pressing questions to the team behind Molecular Devices latest cellular imaging and analysis system to find out how it could make an impact in your lab
Visit booth 3624 to meet the team, pick up a free T-shirt and join in the musical fun as popular singer Alexander Joseph returns with his grand piano
Fluorescent RNA markers molecularly phenotype lesions, providing insight into development of pre-cancerous events
Pico-Surf is designed to offer reliable, highly stable and high-quality droplet generation and processing for microfluidic applications
Download this infographic from Sartorius to find out more about how flow cytometry platforms can be used for immune cell profiling
Drop by SelectScience booth #205 at the SLAS2020 conference January 27-29
Learn about the 3D imaging technologies advancing phenotypic screening at HCS Pharma
Harvard, MIT, and various teaching hospitals team up with industry partners to launch new center for regenerative therapies
Discover the latest technologies and techniques that are revolutionizing immuno-oncology research
Sharad Menon discusses the intricacies of the drug purification process, the techniques his team uses to detect impurities and future trends in biologics testing
The partnership will offer unique patient-derived 3D cell culture services to drug development researchers
Multiplexed immunofluorescence and next-generation image analysis offer spatial insights into the tumor microenvironment